Blog

Access to Medicines

Expanding Vaccine Manufacturing Capacity Solely Within the Pharma Cartel is a Recipe for Perpetual Vaccine Apa... 

Health Justice

President Biden Will Repeal the Global Gag Rule. But That’s Just the First Step. 

Access to Medicines

New ViiV license with the Medicines Patent Pool expands access but eviscerates transparency 

Our Story

Brian Macharia Joins Health GAP 

Access to Medicines

South Africa and India’s Proposal to Waive Recognition and Enforcement of Intellectual Property Rights for C... 

Access to Medicines

Moderna Responds to Activist Pressure, But In the Race for Our Lives, We Need More Than Baby Steps 

Health Justice

Uganda’s Constitutional Court has delivered a major victory for health justice. What comes next for the stru... 

Our Story

Jason Walker joins Health GAP 

Funding the Fight

The World is Failing HIV Positive Kids: What Has Gone Wrong and What We Must Do About It 

Access to Medicines

In Addition to Outrageous Prices and Preferential Supply to the US only, Gilead’s Allowance for Compulsory L... 

Funding the Fight

Will the U.S. Congress Rise to the Moment and Save Lives? Or Will They Let COVID-19 Roll Back Years of Fragile... 

Health Justice

HIV+ People Are More than Two Times Likelier to Die of COVID-19 so Why Aren’t Leaders Doubling Down on the H... 

Access to Medicines

U.S.-, China- and EU-First Nationalism and COVID-19 Technology Hoarding Push the Rest of the World to the End ... 

Access to Medicines

Gilead Remdesivir Licenses: Half Measures are Not Nearly Good Enough 

Access to Medicines

Without a Global Approach to Deadly Inequities in Access to Possible COVID-19 Treatments and Vaccines, Legisla... 

SEE MORE